NCT05590078

Brief Summary

This study evaluate the interest of Virtual Reality to reduce the preoperative anxiety in patients who undergo to ambulatory surgery. Half of the patients will received the virtual reality program, and the other half will received de common treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 21, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

March 21, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2023

Completed
Last Updated

December 22, 2023

Status Verified

December 1, 2023

Enrollment Period

7 months

First QC Date

October 14, 2022

Last Update Submit

December 21, 2023

Conditions

Keywords

Virtual realitypreoperative anxietyanxiety

Outcome Measures

Primary Outcomes (1)

  • Change of Anxiety

    Measured by State-Trait Anxiety Inventory (STAI YA) . The scale includes twenty items.. Each question is assigned 1 to 4 points, giving a score of 20 (low anxiety) to 80 points (high anxiety)

    D0 : baseline and right before going to surgery

Secondary Outcomes (9)

  • Number of milligrams of midazolam administered

    D0 (before surgery)

  • Percentage of patients with intraoperative remifentanil required

    D0 (during surgery)

  • Pain score

    D0 (after surgery)

  • Morphine dose used

    D0 (after surgery in recovery room)

  • Perioperative care satisfaction score

    through study completion, 1 day

  • +4 more secondary outcomes

Study Arms (2)

Control group

OTHER

General routine care. This group will undergo to ambulatory surgery without preoperative virtual reality session. Will be applied the usual treatment to reduce preoperative anxiety.

Other: State Trait Anxiety InventoryOther: Perioperative care satisfaction score

Virtual reality group

EXPERIMENTAL

Virtual Reality. This group will undergo to 20 min virtual reality before ambulatory surgery. In addition to virtual reality session, will be applied the usual treatment to reduce preoperative anxiety, after virtual reality, if necessary.

Device: Virtual reality sessionOther: State Trait Anxiety InventoryOther: Virtual Reality Satisfaction ScoreOther: Perioperative care satisfaction score

Interventions

The 20-minute virtual reality session, in the outpatient department before surgery, immerses the patient in calm environments combined with music therapy and breathing exercises to relax and reduce anxiety.

Virtual reality group

The State Trait Anxiety Inventory (State anxiety) is a questionnaire given to adults that shows how strong a person's feelings of anxiety are "right now, just now". The score is measured on arrival in the outpatient department and just before going into the intervention room (= after the virtual reality session for the experimental group)

Control groupVirtual reality group

Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding virtual reality session

Virtual reality group

Likert scale satisfaction questionnaire to collect the patients' satisfaction regarding perioperative care

Control groupVirtual reality group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II (classification of the American Society of Anesthesiologists).
  • Ambulatory surgery scheduled
  • Score STAI YA \> 45
  • Affiliated to a social security
  • Understanding the study and signing the informed consent

You may not qualify if:

  • Contraindications for Midazolam
  • Patients with disorders not compatible with virtual reality: severe cognitive or psychiatric disorders, blindness, claustrophobia, epilepsy
  • Patient with a pacemaker of others implantable medical devices
  • patient with burns or wounds on the upper face or scalp
  • Visual hallucinations
  • Contagious disease by air or indirect contact
  • Person unable to express their consent
  • Minor patient or patient under curatorship or guardianship
  • patient participating in another interventional clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Arnaud FRIGGERI

    Hospices Civils de Lyon - Centre Hospitalier Lyon Sud

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2022

First Posted

October 21, 2022

Study Start

March 21, 2023

Primary Completion

October 18, 2023

Study Completion

October 18, 2023

Last Updated

December 22, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations